Disease & disorder
chronic kidney disease
MONDO:0005300
Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
40 shownNMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)NCT07820800 · 2026-09-01
RECRUITINGGoal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)NCT07434791 · 2026-08-26
RECRUITINGThe NTU JO-SMART StudyNCT07317310 · 2026-08-01
RECRUITINGLifestyle Intervention In CKDNCT07633145 · 2026-07-30
RECRUITINGArterial Stiffness in Children and Young People With Hypertension and Chronic Kidney DiseaseNCT07768865 · 2026-06-16
RECRUITINGInflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease PatientsNCT07657286 · 2026-06-07
RECRUITINGA Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes MellitusNCT07619157 · 2026-06-02
RECRUITINGAn Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk ScoreNCT07554469 · 2026-05-26
RECRUITINGPeriodontal Disease in Rare Renal Disorders (PERIO-RA-RE)NCT07575347 · 2026-05-04
RECRUITINGEffects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid ArthritisNCT07469540 · 2026-03-16
RECRUITINGImproving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual CareNCT07169422 · 2026-03-01
RECRUITINGSwedish Cardiac And Renal Failure Study-1NCT07029503 · 2026-02-01
RECRUITINGA Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) GuidelinesNCT07561957 · 2026-01-14
RECRUITINGThe Effects of Dietary Nitrate in Patients With Hypertensive Kidney InjuryNCT07290842 · 2025-12-08
RECRUITINGGlucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance DialysisNCT07017270 · 2025-11-27
RECRUITINGAn Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South KoreaNCT07232537 · 2025-11-20
RECRUITINGACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney DiseasesNCT07187713 · 2025-09-20
RECRUITINGUBT251 Injection Phase II Clinical Study (CKD)NCT07134335 · 2025-09-01
RECRUITINGBRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDSNCT07118683 · 2025-08-15
RECRUITINGSingle and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart FailureNCT07259512 · 2025-06-30
RECRUITINGA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortNCT07024823 · 2025-06-09
RECRUITINGValidating Integrative Multi-omics Approaches in Metabolic Syndrome-related DiseasesNCT07248371 · 2025-06-09
RECRUITINGStaged Kidney Transplantation During Combined Heart/Kidney TransplantationNCT06877169 · 2025-04-07
RECRUITINGCardiovascular Risk in Children With Chronic Conditions StudyNCT07086989 · 2025-04-01
RECRUITINGUppsala Self-Screening of Cardiovascular HealthNCT07614659 · 2025-02-01
RECRUITINGCardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF PatientsNCT07237451 · 2025-01-08
RECRUITINGA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseNCT06717698 · 2024-12-02
RECRUITINGAssessment and Management of Multiple Drug Use in Elderly Chronic Disease PatientsNCT07180368 · 2024-10-01
RECRUITINGObesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2NCT06396416 · 2024-09-26
RECRUITINGIntensive Patient Referral and Education Program Prior to Renal Replacement TherapyNCT06397456 · 2024-09-04
RECRUITINGAssociation Between Biomarkers and Kidney Function Decline in Pulmonary HypertensionNCT06409624 · 2024-05-31
RECRUITINGAn Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world ConditionsNCT06278207 · 2024-05-15
RECRUITINGEmpagliflozin Treatment in Kidney Transplant RecipientsNCT06013865 · 2024-04-05
RECRUITINGEvaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney DiseaseNCT06838416 · 2023-11-17
RECRUITINGA Natural History Study of Metabolic Sizing in Health and DiseaseNCT05398783 · 2022-10-25
RECRUITINGThe Epidemiology and Pathophysiology of Kidney Disease in HFpEF With ObesityNCT07052539 · 2022-07-22
RECRUITINGKidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities.NCT03595267 · 2019-10-01
RECRUITINGNanshan Elderly Cohort StudyNCT03569735 · 2018-05-26
RECRUITINGiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesNCT03549754 · 2018-02-17
RECRUITINGOptical Coherence Tomography And NEphropathy: The OCTANE StudyNCT02132741 · 2014-05-16
RECRUITINGDrugs being studied
Research locations
San AntonioTexas, United States19HoustonTexas, United States15ChicagoIllinois, United States14BarcelonaSpain13DallasTexas, United States13MadridSpain13SeoulSouth Korea13Los AngelesCalifornia, United States12BerlinGermany10MiamiFlorida, United States10WarsawPoland10BostonMassachusetts, United States9
Leading sponsors
Bayer23Novo Nordisk A/S7VA Office of Research and Development7AstraZeneca6AbbVie (prior sponsor, Abbott)5Duke University5Prokidney4Baylor Research Institute3Eli Lilly and Company3Kyowa Kirin Co., Ltd.3University of Erlangen-Nürnberg Medical School3University of Florida3Assiut University2Biogen2Chinese University of Hong Kong2
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.